100 related articles for article (PubMed ID: 23057547)
1. HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors.
Fuerst D; Parmar S; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kaechele V; Stiebel K; Paul T; Seufferlein T; Mytilineos J; Stingl JC
Pharmacogenomics; 2012 Oct; 13(13):1469-76. PubMed ID: 23057547
[TBL] [Abstract][Full Text] [Related]
2. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
[TBL] [Abstract][Full Text] [Related]
3. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Parham LR; Briley LP; King KS; Byrne J; Rappold E; Goss PE; Spraggs CF
Pharmacogenomics; 2015; 16(11):1227-9. PubMed ID: 26265235
[TBL] [Abstract][Full Text] [Related]
4. Clinical research of EGFR inhibitors and related dermatologic toxicities.
Perez-Soler R; Van Cutsem E
Oncology (Williston Park); 2007 Oct; 21(11 Suppl 5):10-6. PubMed ID: 18154213
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib.
Guttman-Yassky E; Mita A; De Jonge M; Matthews L; McCarthy S; Iwata KK; Verweij J; Rowinsky EK; Krueger JG
Eur J Cancer; 2010 Jul; 46(11):2010-9. PubMed ID: 20621734
[TBL] [Abstract][Full Text] [Related]
6. Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.
Waris W; Naik S; Idrees I; Taha H; Camosino L; Mehrishi A; Saif MW
Cutan Ocul Toxicol; 2009; 28(1):41-4. PubMed ID: 19514925
[TBL] [Abstract][Full Text] [Related]
7. Higher severity grade of erlotinib-induced rash is associated with lower skin phototype.
Luu M; Boone SL; Patel J; Sullivan P; Rademaker AW; Balagula Y; Lacouture ME
Clin Exp Dermatol; 2011 Oct; 36(7):733-8. PubMed ID: 21689147
[TBL] [Abstract][Full Text] [Related]
8. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
9. A new HLA-B*15 allele, B*15:220, found in three individuals sharing the HLA-A*66:01, HLA-C*12:03 and HLADRB1*07:01 alleles.
Schell A; Leisenbach R; Coman C; Parissiadis A; Tourne S
Tissue Antigens; 2011 Oct; 78(4):287-8. PubMed ID: 21732916
[TBL] [Abstract][Full Text] [Related]
10. HLA markers for susceptibility and expression in scleroderma.
Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic predictors for EGFR-inhibitor-associated skin toxicity.
Parmar S; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kächele V; Seeringer A; Paul T; Seufferlein T; Stingl JC
Pharmacogenomics J; 2013 Apr; 13(2):181-8. PubMed ID: 22158333
[TBL] [Abstract][Full Text] [Related]
12. Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
Klinghammer K; Knödler M; Schmittel A; Budach V; Keilholz U; Tinhofer I
Clin Cancer Res; 2010 Jan; 16(1):304-10. PubMed ID: 20028750
[TBL] [Abstract][Full Text] [Related]
13. Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia.
Chen C; Lu S; Luo M; Zhang B; Xiao L
Acta Haematol; 2012; 128(1):23-7. PubMed ID: 22572536
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.
Osio A; Mateus C; Soria JC; Massard C; Malka D; Boige V; Besse B; Robert C
Br J Dermatol; 2009 Sep; 161(3):515-21. PubMed ID: 19466958
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos.
Aláez C; Flores-A H; Concha del Río LE; Munguía A; Rodríguez A; García D; Arellanes L; Gorodezky C
Hum Immunol; 2011 Dec; 72(12):1198-203. PubMed ID: 21964432
[TBL] [Abstract][Full Text] [Related]
16. HLA-B*51:79 is a novel allele associated with a conserved haplotype.
Perrier P; Leisenbach R; Tourne S; Kennel A; Proust B
Tissue Antigens; 2011 Oct; 78(4):288-9. PubMed ID: 21671889
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 236 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci from China Marrow Donor Program.
Li J; Qu J; Zhang X; Zhang C; Liu Y; Cao H; Zhang W; Wang Y; Chen H; Chen G; Zheng Z; Shen M; Cheng Z; Tang J; Zhen H; Liao K; Chen C; Yang H; Tian Z; Zhang H; Hua S; Rao B; Wang N; Zhang Q; Liu T; Chen S; Wang L; Yi X
Tissue Antigens; 2011 Oct; 78(4):267-70. PubMed ID: 21732917
[TBL] [Abstract][Full Text] [Related]
18. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis].
Liu HY; Deng AM; Zhang J; Zhou Y; Yao DK; Shen F; Tu XQ; Fan LY; Zhong RQ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):410-3. PubMed ID: 15975271
[TBL] [Abstract][Full Text] [Related]
20. HLA typing in Taiwanese patients with oral submucous fibrosis.
Chen HM; Hsieh RP; Yang H; Kuo YS; Kuo MY; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):191-9. PubMed ID: 15061705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
